Search Results - "SHIFF, Natalie J"

Early Improvements with Guselkumab Associate with Sustained Control of Psoriatic Arthritis: Post hoc Analyses of Two Phase 3 Trials by Curtis, Jeffrey R., Deodhar, Atul, Soriano, Enrique R., Rampakakis, Emmanouil, Shawi, May, Shiff, Natalie J., Han, Chenglong, Tillett, William, Gladman, Dafna D.

“…Introduction Patterns of treatment response can inform clinical decision-making. This study assessed the course and impact of achieving minimal clinically…”
Get full text

Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry by Mease, Philip J., Ogdie, Alexis, Tesser, John, Shiff, Natalie J., Lin, Iris, Chakravarty, Soumya D., Kelleman, Michael, Dodge, Rhiannon, McLean, Robert R., Broadwell, Aaron, Kavanaugh, Arthur, Merola, Joseph F.

“…Introduction The aim of this work is to evaluate treatment persistence and clinical outcomes after 6 months of on-label guselkumab use in patients with…”
Get full text

Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors by Walsh, Jessica A., Lin, Iris, Zhao, Ruizhi, Shiff, Natalie J., Morrison, Laura, Emond, Bruno, Yu, Louise H., Schwartzbein, Samuel, Lefebvre, Patrick, Pilon, Dominic, Chakravarty, Soumya D., Mease, Philip

“…Background Treatment persistence among patients with psoriatic arthritis (PsA) is essential for achieving optimal treatment outcomes. Guselkumab, a fully human…”
Get full text

Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study by Coates, Laura C, Gossec, Laure, Zimmermann, Miriam, Shawi, May, Rampakakis, Emmanouil, Shiff, Natalie J, Kollmeier, Alexa P, Xu, Xie L, Nash, Peter, Mease, Philip J, Helliwell, Philip S

“…ObjectiveEvaluate long-term guselkumab effectiveness across Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-recognised…”
Get full text

Patient factors associated with waiting time to pediatric rheumatologist consultation for patients with juvenile idiopathic arthritis by Barber, Claire E H, Barnabe, Cheryl, Benseler, Susanne, Chin, Ricky, Johnson, Nicole, Luca, Nadia, Miettunen, Paivi, Twilt, Marinka, Veeramreddy, Dwaraka, Shiff, Natalie J, Schmeling, Heinrike

“…Early diagnosis and treatment of Juvenile Idiopathic Arthritis (JIA) is essential to optimize outcomes. Wait times (WTs) to consultation with a pediatric…”
Get full text

Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study by Bingham, Clifton O., Black, Shawn, Shiff, Natalie J., Xu, Stephen, Langholff, Wayne, Curtis, Jeffrey R.

“…Introduction To assess changes in the Patient-Reported Outcomes Measurement Information System (PROMIS ® ) outcomes related to social, mental, and physical…”
Get full text

Testing population-based performance measures identifies gaps in juvenile idiopathic arthritis (JIA) care by Barber, Claire E H, Lix, Lisa M, Lacaille, Diane, Marshall, Deborah A, Kroeker, Kristine, Benseler, Susanne, Twilt, Marinka, Schmeling, Heinrike, Barnabe, Cheryl, Hazlewood, Glen S, Bykerk, Vivian, Homik, Joanne, Thorne, J Carter, Burt, Jennifer, Mosher, Dianne, Katz, Steven, Shiff, Natalie J

“…The study evaluates Performance Measures (PMs) for Juvenile Idiopathic Arthritis (JIA): The percentage of patients with new onset JIA with at least one visit…”
Get full text

Improvements in Patient-Reported Outcomes Through Six Months of Guselkumab Treatment in Patients With Active Psoriatic Arthritis: Real-World Data From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry by Mease, Philip J, Ogdie, Alexis, Tesser, John, Shiff, Natalie J, Zhao, Ruizhi Sophia, Chakravarty, Soumya D, Kelleman, Michael, Dodge, Rhiannon, McLean, Robert R, Broadwell, Aaron, Kavanaugh, Arthur, Merola, Joseph F

“…Evaluate patient-reported outcomes after 6 months of on-label guselkumab use in patients with rheumatologist-diagnosed active psoriatic arthritis (PsA)…”
Get full text

Work Productivity and General Health Through 2 Years of Guselkumab Treatment in a Phase 3 Randomized Trial of Patients With Active Psoriatic Arthritis by Curtis, Jeffrey R., McInnes, Iain B., Rahman, Proton, Gladman, Dafna D., Peterson, Steven, Yang, Feifei, Adejoro, Oluwakayode, Kollmeier, Alexa P., Shiff, Natalie J., Han, Chenglong, Shawi, May, Tillett, William, Mease, Philip J.

“…Introduction To evaluate the effect of guselkumab on work productivity and nonwork daily activity impairment and general health status through 2 years in…”
Get full text

Predictors of persisting pain in children with Juvenile Idiopathic Arthritis: a case control study nested in the ReACCh-Out cohort by McGrath, Tara, Guzman, Jaime, Tucker, Lori, Shiff, Natalie J, Yaskina, Maryna, Tupper, Susan, Rumsey, Dax G, Benseler, Susanne, Berard, Roberta, Boire, Gilles, Bolaria, Roxana, Cabral, David, Cameron, Bonnie, Campillo, Sarah, Chan, Mercedes, Chédeville, Gaëlle, Chetaille, Anne-Laure, Dancey, Paul, Dorval, Jean, Duffy, Ciarán, Ellsworth, Janet, Feldman, Brian, Feldman, Debbie, Gross, Katherine, Haddad, Ellie, Houghton, Kristin, Huber, Adam, Johnson, Nicole, Jurencak, Roman, Lang, Bianca, LarcheÌ, Maggie, Laxer, Ronald, LeBlanc, Claire, Levy, Deborah, Luca, Nadia, Miettunen, Paivi, Morishita, Kimberly, Oen, Kiem, Petty, Ross, Ramsey, Suzanne, Rosenberg, Alan, Roth, Johannes, Saint-Cyr, Claire, Schmeling, Heinrike, Schneider, Rayfel, Silverman, Earl, Spiegel, Lynn, Stringer, Elizabeth, Scuccimarri, Rosie, Tse, Shirley, Turvey, Stuart, Duffy, Karen Watanabe, Yeung, Rae

“…Background To identify baseline predictors of persisting pain in children with Juvenile Idiopathic Arthritis (JIA), relative to patients with JIA who had…”
Get full text

Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study by Broadwell, Aaron, Schechtman, Joy, Conaway, Douglas, Kivitz, Alan, Shiff, Natalie J, Black, Shawn, Xu, Stephen, Langholff, Wayne, Schwartzman, Sergio, Curtis, Jeffrey R

“…Biologic therapies are often prescribed for patients with rheumatoid arthritis (RA) who have inadequate responses to or are intolerant of methotrexate (MTX)…”
Get full text

Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE Study by Deodhar, Atul, Shiff, Natalie J., Gong, Cinty, Chan, Eric K. H., Hsia, Elizabeth C., Lo, Kim Hung, Akawung, Alianu, Kim, Lilianne, Xu, Stephen, Reveille, John D.

“…Introduction We studied the effect of intravenous (IV)-golimumab on fatigue and the association of fatigue improvement with clinical response post hoc in…”
Get full text

Pharmacosurveillance in Juvenile Idiopathic Arthritis by Shiff, Natalie J., Beukelman, Timothy

“…The advent of biologic disease-modifying antirheumatic drugs targeting specific cytokines or cell-cell interactions has dramatically changed the outlook of…”
Get full text

Trends in Population‐Based Incidence and Prevalence of Juvenile Idiopathic Arthritis in Manitoba, Canada by Shiff, Natalie J., Oen, Kiem, Kroeker, Kristine, Lix, Lisa M.

“…Objective To estimate the incidence and prevalence of juvenile idiopathic arthritis (JIA) in children ages <16 years in the province of Manitoba, Canada, and…”
Get full text

Effectiveness and Safety of High‐Dose Biologics in Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance by Correll, Colleen K., Shrader, Peter, Dennos, Anne, Phillips, Thomas, Shiff, Natalie J., Verstegen, Ruud H. J., Beukelman, Timothy

“…Objective To describe high‐dose biologic use when treating juvenile idiopathic arthritis (JIA). Methods Patients with JIA enrolled in the Childhood Arthritis…”
Get full text

Access to Pediatric Rheumatology Subspecialty Care in British Columbia, Canada by SHIFF, Natalie J, ABDWANI, Reem, CABRAL, David A, HOUGHTON, Kristin M, MALLESON, Peter N, PETTY, Ross E, ESPINOSA, Victor M, TUCKER, Lori B

“…Objective. Early recognition and treatment of pediatric rheumatic diseases is associated with improved outcome. We documented access to pediatric rheumatology…”
Get full text

Predicting Which Children with Juvenile Idiopathic Arthritis Will Have a Severe Disease Course: Results from the ReACCh-Out Cohort by Guzman, Jaime, Henrey, Andrew, Loughin, Thomas, Berard, Roberta A, Shiff, Natalie J, Jurencak, Roman, Benseler, Susanne M, Tucker, Lori B

“…We studied an inception cohort of children with juvenile idiopathic arthritis (JIA) to (1) identify distinct disease courses based on changes over 5 years in 5…”
Get full text

Improvement in disease activity among patients with rheumatoid arthritis who switched from intravenous infliximab to intravenous golimumab in the ACR RISE registry by Tesser, John, Lin, Iris, Shiff, Natalie J., Chakravarty, Soumya D., Schmajuk, Gabriela, Hammam, Nevin, Desai, Sheetal

“…Infliximab and golimumab are intravenously (IV) administered tumor necrosis factor inhibitors approved to treat moderate-to-severe rheumatoid arthritis (RA)…”
Get full text

Evaluating Quality of Care for Rheumatoid Arthritis for the Population of Alberta Using System-level Performance Measures by Barber, Claire E H, Lacaille, Diane, Faris, Peter, Mosher, Dianne, Katz, Steven, Patel, Jatin N, Zhang, Sharon, Yee, Karen, Barnabe, Cheryl, Hazlewood, Glen S, Bykerk, Vivian, Shiff, Natalie J, Twilt, Marinka, Burt, Jennifer, Benseler, Susanne M, Homik, Joanne, Marshall, Deborah A

“…We evaluated 4 national rheumatoid arthritis (RA) system-level performance measures (PM) in Alberta, Canada. Incident and prevalent RA cases ≥ 16 years of age…”
Get full text

A Population‐Based Approach to Reporting System–Level Performance Measures for Rheumatoid Arthritis Care by Barber, Claire E. H., Marshall, Deborah A., Szefer, Elena, Barnabe, Cheryl, Shiff, Natalie J., Bykerk, Vivian, Homik, Joanne, Thorne, J. Carter, Ahluwalia, Vandana, Benseler, Susanne, Mosher, Dianne, Twilt, Marinka, Lacaille, Diane

“…Objective To operationalize and report on nationally endorsed rheumatoid arthritis (RA) performance measures (PMs) using health administrative data for British…”
Get full text